• Non ci sono risultati.

Scarica il programma in formato PDF

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma in formato PDF"

Copied!
2
0
0

Testo completo

(1)

32 nd annual Meeting

of the

European Musculo Skeletal

Oncology Society

20

th

EMSOS nurse and allied

professions group

meeting

Florence Italy

May 15 - 17 2019

www.emsos2019.eu

Cal l f

or A bstr

ac ts

Dead -lin e: F

ebr uar y 1

, 201 9

(2)

• New Technologies in Orthopaedic Oncology

• New drugs in Sarcoma Therapy:

new agents, target therapies, immunotherapy

• New drugs in tumor-like disease

• New strategies in Radiationtherapy

• Advances in Imaging Technology

• Computer assisted surgery and Robotics

• Augmented Reality

• Custom-Made Prosthesis and Devices

• Patient Specific Instruments

• Paediatric Orthopaedic Oncology

• Lenghtening prostheses and devices

• Spine and Sacral Tumors

• Infection:

new strategies in prevention and treatment

• Implant coating

• Mininvasive Therapies in Orthopaedic Oncology

• New devices after amputation

• “Salvage of Limb Salvage”

32

nd

Annual Meeting

for further information

www.emsos2019.eu

European Musculo-Skeletal Oncology Society

E.M.S.O.S.

Main Topics:

32

nd

annual Meeting of the

European Musculo Skeletal Oncology Society

Organizing Committee:

President Domenico Andrea Campanacci Honorary President Rodolfo Capanna LOCAL WORKING COMMITTEE Giovanni Beltrami – Treasurer Lorenzo Andreani Simone Colangeli Pierluigi Cuomo Filippo Frenos Davide Matera Nicola Mondanelli Francesco Muratori Guido Scoccianti Maurizio Scorianz Francesca Totti

SCIENTIFIC SECRETARIAT Dept. of Surgery and Translational Medicine

UNIVERSITY OF FLORENCE

Largo Brambilla 3 • 50134 Florence • Italy OIC Srl is a MedTech Trusted Partner

ORGANISING SECRETARIAT Ph. +39 055 50351 • www.oic.it

[email protected]

ABSTRACT SUBMISSION

The Scientific Committee invites you to participate in this Meeting by submitting on-line ( www.emsos 2019.eu ) your abstract

ABSTRACT SUBMISSION IS OPEN UNTIL FEBRUARY 1, 2019

Riferimenti

Documenti correlati

Attanasio Roberto, Milano Berretti Debora, Udine Berruti Alfredo, Brescia Bertani Emilio, Milano Bertolissi Fabio, Udine Borretta Giorgio, Cuneo Carpentieri Maria, Udine

Questo corso scaturisce dalla necessità di un confronto continuo delle esperienze disponibili sugli articolati aspetti della medicina oncologica e dalla

III° MODULO - Tumori nell’Uomo: oncologia, psiconcologia .Coppia e sessualità - 10/11 Giugno IV° MODULO - Tumori nel Bambino: oncologia e psiconcologia - 30 Settembre/1 Ottobre

− Ca mammario postmenopausale, in fase avanzata, recettori ormonali positivi (everolimus, SERMS, inibitori delle aromatasi). − Ca mammario HER2 positivo in fase localmente avanzata

MASSIMO AGLIETTA CANDIOLO OSCAR BERTETTO TORINO ENRICO BOLLITO ORBASSANO GIARIO CONTI COMO RENZO CORVÒ GENOVA STEFANO DE LUCA ORBASSANO PAOLA FRANZONE ALESSANDRIA DOMENICO

Management of cardiovascular risk and hormonal deprivation in prostate cancer Il management del rischio cardiovascolare e della deprivazione ormonale nel cancro

12.00 LA CARATTERIzzAzIONE BIO-PATOLOGICA NEL PERCORSO DIAGNOSTICO-TERAPEUTICO: IL

13.45 What we need to know about biological bases of cancer immunotherapy Nicola Tinari (Chieti) 14.05 Biomarkers of response to immune checkpoint inhibitors Antonio